On Saturday, the Head of the Scientific Advisory Committee to Combat the COVID-19 Pandemic, Khalifa Al-Bakoush, confirmed that Libya will soon receive about 12 million doses of the coronavirus vaccine in batches.
In press statements, Al-Bakoush that they had contracted 4 companies, namely, Moderna, AstraZeneca, Pfizer, and Johnson & Johnson to secure more vaccines as soon as they are made available.
He explained that the first batch of vaccines estimated at about 1 million doses will arrive in early March.
He explained that the reason for the delay in the arrival of the vaccine in Libya is due to the shutdown imposed by the European Union.
He indicated that the epidemiological situation in Libya has stabilized in recent weeks compared to other countries. He pointed out that medical authorities are working to provide the vaccine for the entire population.
It is noteworthy that Libya has contracted to buy 2.8 million doses of the COVID-19 vaccine, at a value of 42 million Libyan dinars.
Libya’s Head of the Supreme Committee for Vaccinations, Suleiman Abusriwil, also said that the first batch of vaccines estimated at about 1 million doses will arrive in early March.
Abusriwil added that this batch includes 55,000 doses of the Pfizer vaccine and more than 900,000 doses of the Oxford AstraZeneca vaccine.